Research

The faculty members in the Hematology/Oncology Division maintain active clinical, translational, and epidemiology research programs.

Translational Research

Epidemiology / Public Health


Clinical Research

The Hematology/Oncology Division in alliance with the University of Vermont Cancer Center and The University of Vermont Medical Center lead and participate in clinical trials in our region and nationally. Clinical research includes treatment and prevention protocols and investigator-initiated, cooperative group, and industry trials.

Collaborations

Collaborations with researchers in other University of Vermont departments (including Pathology, Biochemistry, Microbiology and Molecular Genetics, Psychology and Health Promotion) and with national and international colleagues increase available clinical and basic science projects. Biostatistical support is available through the University of Vermont Cancer Center.

Funding

Research activities carried out within the Division are supported by grants from the National Cancer Institute, National Heart, Lung and Blood Institute, National Institute of Neurological Disorders and Stroke, the Department of Defense, the American Cancer Society, the American Heart Association, the Hemophilia and Thrombosis Research Society and industry collaborations

L-R: Jacob Barker, PharmD.; Emily Parenteau, M.S.N., APRN; Karen Libby, BSN; Chris Holmes, M.D., Ph.D., Steven Ades, M.D., M.Sc.

L-R: Jacob Barker, PharmD.; Emily Parenteau, M.S.N., APRN; Karen Libby, BSN; Chris Holmes, M.D., Ph.D., Steven Ades, M.D., M.Sc.

Steven Ades, M.D., associate professor in the Division of Hematology/Oncology, is principal investigator for a Northern New England Clinical Oncology Society grant titled “VTE Risk Assessment and Prevention in Cancer Patients in the Community Oncology Setting.” Co-investigators are Chris Holmes, M.D., Ph.D.; Yonatan Resnick, PharmD; Christian Thomas, M.D.; Jacob Barker, PharmD; Emily Parenteau, P.A.; and Karen Libby, R.N.